Umedica Laboratories Pvt Ltd
General
Total Cases5
Active Cases1
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/02/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 8,877,938; 9,388,134; 9,517,226; 9,937,143; 11,058,667; 11,096,918; 11,135,192. (nms) (Entered: 01/02/2025) | |
| 01/02/25 | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 01/02/2025) | |
| 01/02/25 | CASE CLOSED per entry of D.I. [6] . (nms) (Entered: 01/02/2025) | |
| 01/02/25 | Remark: The related case information for this Civil Action has been updated to reflect this case is a member to MDL 20-md-2930-RGA and the MDL Panel has been notified. (oam) Modified on 1/2/2025 (nms). (Entered: 01/02/2025) | |
| 12/26/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (oam) (Entered: 12/26/2024) | |
| 12/26/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,667; 11,096,918; 11,135,192. (oam) (Entered: 12/26/2024) | |
| 12/26/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 8,877,938; 9,388,134; 9,517,226 ; 9,937,143. (oam) (Entered: 12/26/2024) | |
| 12/26/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/12/24. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/12/2027. (oam) (Entered: 12/26/2024) | |
| 12/26/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 12/26/2024) | |
| 12/26/24 | No Summons Issued. (oam) (Entered: 12/26/2024) |